The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Associations between patient (pt) colorectal cancer (CRC) tumor KRAS and BRAF mutation (mut) status and overall survival (OS).
Hesham M. Hassabo
No relevant relationships to disclose
Ibrahim Halil Sahin
No relevant relationships to disclose
Syed Mohammad Ali Kazmi
No relevant relationships to disclose
Salwan S. Al Mutar
No relevant relationships to disclose
Diogo Bugano Diniz Gomes
No relevant relationships to disclose
Tunghi May Pini
No relevant relationships to disclose
Eduardo Vilar Sanchez
No relevant relationships to disclose
Arvind Dasari
No relevant relationships to disclose
Scott Kopetz
No relevant relationships to disclose
Michael J. Overman
No relevant relationships to disclose
Cathy Eng
No relevant relationships to disclose
Bryan K Kee
No relevant relationships to disclose
Jean-Nicolas Vauthey
No relevant relationships to disclose
Manal Hassan
No relevant relationships to disclose
Chris R. Garrett
No relevant relationships to disclose